118 related articles for article (PubMed ID: 3734263)
1. Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure.
Arnold JM; Ludmer PL; Wright RF; Ganz P; Braunwald E; Colucci WS
J Am Coll Cardiol; 1986 Aug; 8(2):413-8. PubMed ID: 3734263
[TBL] [Abstract][Full Text] [Related]
2. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
3. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
4. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Colucci WS
Am J Cardiol; 1989 Jan; 63(2):17A-22A. PubMed ID: 2909993
[TBL] [Abstract][Full Text] [Related]
5. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
6. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
7. Modulation of venous tone in heart failure.
Muir AL; Nolan J
Am Heart J; 1991 Jun; 121(6 Pt 2):1948-50. PubMed ID: 2035425
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
9. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D
Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
[TBL] [Abstract][Full Text] [Related]
10. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
Mager G; Steffen HM; Klocke RK; Wambach G; Kux A; Degenhardt S; Höpp HW; Hilger HH
Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
13. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
14. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
[TBL] [Abstract][Full Text] [Related]
15. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
[TBL] [Abstract][Full Text] [Related]
16. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
17. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
[TBL] [Abstract][Full Text] [Related]
18. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
[TBL] [Abstract][Full Text] [Related]
20. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
